Oh look, another nasty problem for Valeant (VRX)

T. Rowe Price is suing Valeant Pharmaceuticals, alleging fraud, according to The Wall Street Journal.
The mutual fund is an investor in the company.
In the suit, it accuses Valeant of running a "fraudulent scheme" through its now defunct pharmacy, Philidor.
The fund says in the suit that Valeant's secret network of pharmacies used deceptive practices to sell drugs, then hid the source of these ill-gotten gains with accounting.
All of this, T. Rowe claims, was done in an effort to preserve Valean